Modified Vaccinia Ankara (MVA) Vaccine Study

计划入组 18 人 · 首次发布于 2010 年 12 月 9 日

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

计划入组 80 人 · 首次发布于 2003 年 2 月 5 日

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

计划入组 36 人 · 首次发布于 2006 年 10 月 11 日

Modified vaccinia ankara(Jynneos)

Measles virus vaccine live attenuated(M-M-R II, Proquad)

HIV DNA vaccine (University of Oxford)

AIM VACCINE

China

Hualan Biological Vaccine Inc.

China

Live Verdure Ltd

China's First Monkeypox Vaccine Enters Phase I Clinical Trials with Diverse Volunteer Cohort

EU Approves Label Extension for Bavarian Nordic's Imvanex Mpox Vaccine to Children Aged 2 and Older

MVA-MERS-S Vaccine Shows Safety and Efficacy in Phase Ib Trial Against MERS-CoV